Autonomix Medical Inc (NASDAQ:AMIX) saw its stock climb 13% after the medical device firm announced it received a patent from the U.S. Patent and Trademark Office for its innovative “Smart Torquer” technology.
The newly granted patent (No. 12,295,646) protects a smart torquer device engineered to improve the handling of intravascular instruments during minimally invasive procedures, incorporating electronic elements for mechanical control as well as data communication.
Brad Hauser, CEO of Autonomix, said, “This patent strengthens our intellectual property portfolio and reinforces our commitment to developing differentiated technologies that address large and underserved markets. The smart torquer improves control and signal integration for intravascular procedures, which is essential for expanding our platform into high-growth areas like cardiology, neurosurgery, and interventional radiology.”
The patent covers an engaging mechanism that securely connects to intravascular devices, a communication module for data transfer, an electrical interface for signal transmission, and a manipulator allowing operators to apply torque to navigate through the vascular system.
Autonomix is also advancing a catheter-based microchip sensing array antenna, designed to detect and distinguish neural signals with superior sensitivity compared to current solutions. Its proprietary RF ablation technology aims to deliver precise, targeted treatments for ailments such as chronic pain and hypertension.
This new patent adds to Autonomix’s growing portfolio of over 80 patents, further bolstering its leadership in the precision nerve-targeting treatment field.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.